SGLT2 inhibitors may enable continuation of RAAS inhibitors for hypertension treatment, which is linked with better kidney and cardiovascular outcomes.

Patients with DME who are treated using aflibercept are more likely to experience acute kidney injury or hospitalisation due to renal events than those treated with ranibizumab. Using a target ...

The rate of offers per candidate represents a threefold increase compared with 2015. (HealthDay News) — The number of kidney transplants performed annually in the United States has increased ...

The prophylactic efficacy of TMP-SMX was significantly higher in subgroups with baseline lymphopenia, azotemia, microscopic polyangiitis, or relapsed AAV.

Geographic disparities seen, with greater percentage of cardiovascular deaths attributable to di-2-ethylhexylphthalate exposure for South Asia, Middle East.

No significant difference seen in urodynamic testing results between TPTNS and rTMS groups. (HealthDay News) — For female patients with multiple sclerosis (MS), transcutaneous posterior tibial ...

Authors say findings do not support routine hormone use in the perimenopausal and postmenopausal periods. (HealthDay News) — Hormone therapy use is linked to worse bladder health in postmenopausal ...

Sustainable development efforts such as lowering out-of-pocket health expenses can reduce future prevalence of AMR by 5.1 percent.